Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raderer

Showing results (101-110 of 172) with videos related to

Pageof 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 16, 2007
Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseasesS Wöhrer, M Troch, J Zwerina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cellsB J Fueger, G Hamilton, M Raderer, et al.
European Journal of Nuclear Medicine|November 5, 1997
Radiation doses deriving from patients undergoing 111In-DTPA-D-phe-1-octreotide scintigraphyA Kurtaran, J Pfreitfellner, P Schaffarich, et al.
World Journal of Nuclear Medicine|December 7, 2011
Improved quality of life in patients treated with Peptide radionuclidesT Traub-Weidinger, M Raderer, M Uffmann, et al.
Cancer|May 17, 2000
Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIEM Raderer, J Valencak, C Osterreicher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbuminA Kurtaran, C Müller, G Novacek, et al.
British Journal of Cancer|August 17, 2000
Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphomaM Raderer, F Vorbeck, M Formanek, et al.
International Journal of Oncology|May 17, 2000
Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivoM Raderer, M H Hejna, C Muller, et al.
Journal of the National Cancer Institute|April 28, 1999
Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue typeM Raderer, J Valencak, F Pfeffel, et al.
Cancer|April 3, 2001
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trialW Scheithauer, G V Kornek, H Ulrich-Pur, et al.
Pageof 18

Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 16, 2007
Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseasesS Wöhrer, M Troch, J Zwerina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cellsB J Fueger, G Hamilton, M Raderer, et al.
European Journal of Nuclear Medicine|November 5, 1997
Radiation doses deriving from patients undergoing 111In-DTPA-D-phe-1-octreotide scintigraphyA Kurtaran, J Pfreitfellner, P Schaffarich, et al.
World Journal of Nuclear Medicine|December 7, 2011
Improved quality of life in patients treated with Peptide radionuclidesT Traub-Weidinger, M Raderer, M Uffmann, et al.
Cancer|May 17, 2000
Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIEM Raderer, J Valencak, C Osterreicher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbuminA Kurtaran, C Müller, G Novacek, et al.
British Journal of Cancer|August 17, 2000
Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphomaM Raderer, F Vorbeck, M Formanek, et al.
International Journal of Oncology|May 17, 2000
Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivoM Raderer, M H Hejna, C Muller, et al.
Journal of the National Cancer Institute|April 28, 1999
Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue typeM Raderer, J Valencak, F Pfeffel, et al.
Cancer|April 3, 2001
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trialW Scheithauer, G V Kornek, H Ulrich-Pur, et al.
Pageof 18